Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long SNPS Daily ETF

28.77
+2.489.43%
Volume:18.42K
Turnover:527.15K
Market Cap:1.87M
PE:- -
High:29.27
Open:28.40
Low:27.83
Close:26.29
52wk High:43.54
52wk Low:22.40
Shares:65.00K
Float Shares:45.00K
Volume Ratio:1.98
T/O Rate:40.93%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Tradr 2X Long SNPS Daily ETF
Exchange:
CBOE
Establishment Date:
2025
Employees:
- -
Office Location:
181 Westchester Avenue,Suite 402,Port Chester,New York,United States
Zip Code:
10573
Fax:
- -
Introduction:
Synaptogenix, Inc. operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and niemann-pick type C disease. It has licensing agreements with Stanford University; Icahn School of Medicine; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is based in New York, New York.